ストックスクリーナーアプリを入手
0.5299
5.12%
0.0258
アフターアワーズ：
.51
-0.0199
-3.76%
前日終値:
$0.5041
開ける：
$0.5166
24時間の取引高:
578.17K
Relative Volume:
0.21
時価総額：
$2.59M
収益：
$14.64M
当期純損益:
$-13.74M
株価収益率:
-0.0506
EPS:
-10.47
ネットキャッシュフロー:
$-5.04M
1週間 パフォーマンス:
-7.83%
1か月 パフォーマンス:
-25.26%
6か月 パフォーマンス:
-76.76%
1年 パフォーマンス:
-94.45%
1日の値動き範囲:
$0.5046
$0.5299
1週間の範囲:
$0.49
$0.5749
52週間の値動き範囲:
$0.3611
$9.10
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
名前
Novabay Pharmaceuticals Inc
セクター
電話
510-899-8800
住所
2000 Powell Street, Suite 1150, Emeryville, CA
NBY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
0.5299 | 2.59M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-09-18 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-07-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-15 | 繰り返されました | Laidlaw | Buy |
| 2017-06-05 | 開始されました | ROTH Capital | Buy |
| 2017-03-27 | 開始されました | Laidlaw | Buy |
| 2017-02-06 | 開始されました | Rodman & Renshaw | Buy |
| 2016-03-07 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-14 | 繰り返されました | Maxim Group | Buy |
| 2015-04-30 | 再開されました | Maxim Group | Buy |
| 2013-03-06 | 開始されました | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 開始されました | Dawson James | Speculative Buy |
すべてを表示
Novabay Pharmaceuticals Inc (NBY) 最新ニュース
NovaBay Pharmaceuticals Adjourns Special Meeting Due to Insufficient Votes - Defense World
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - BioSpace
NovaBay Pharmaceuticals Delays Critical Vote on Avenova Sale and Company Dissolution Amid Vote Shortage - StockTitan
NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews.com - Defense World
NovaBay®Pharmaceuticals, Inc. Launches NovaWipes Eyelid Wipes on Amazon.com - Marketscreener.com
NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com - Defense World
NBYNovaBay Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - BioSpace
NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.com - Defense World
NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by Analysts at StockNews.com - Defense World
NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024 - BioSpace
NovaBay Postpones Key Vote on Asset Sale, Liquidation Plans Amid Low Turnout | NBY Stock News - StockTitan
NovaBay calls for affirmative vote on asset sale and dissolution - Investing.com
NovaBay calls for affirmative vote on asset sale and dissolution By Investing.com - Investing.com UK
NovaBay Pharmaceuticals Reports Q3 2024 Financials Amid Strategic Changes - TipRanks
NovaBay Pharmaceuticals Reports Third Quarter 2024 Results, Accepts Revised Offer to Sell Avenova Brand - Vision Monday
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results - StockTitan
NovaBay accepts higher PRN offer, says Refresh deal no longer superior - MSN
NovaBay agrees to increased offer for eyecare unit - Investing.com
NovaBay agrees to increased offer for eyecare unit By Investing.com - Investing.com UK
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price - StockTitan
NovaBay Pharmaceuticals : Signs Distribution Agreement With the Biopharm Group - Marketscreener.com
# NovaBay Pharmaceuticals Considers Acquisition Offer in Recent SEC Filing - Defense World
NovaBay Pharmaceuticals receives unsolicited offer from Refresh Acquisitions - MSN
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC - StockTitan
NovaBay to sell Avenova assets - Healio
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell Its Avenova AssetsVision Monday - Vision Monday
Novabay Pharmaceuticals Inc (NBY) Stock: A Year of Market Fluctuations - The InvestChronicle
Before You Invest, Make Sure You Check This Novabay Pharmaceuticals Inc (AMEX: NBY) Analysis - Stocks Register
Novabay Pharmaceuticals Inc (NBY)’s Market Momentum: Closing Strong at 0.70, Down -5.62 - The Dwinnex
NovaBay Pharmaceuticals, Inc. announced that it expects to receive $2.83 million in funding from Pioneer Pharma Pte. Ltd. and other investors. - Marketscreener.com
A new trading data show Novabay Pharmaceuticals Inc (NBY) is showing positive returns. - SETE News
Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm - PR Newswire
What's Going On With NovaBay Pharmaceuticals Shares Friday? - Benzinga
NBY’s price-to-free cash flow ratio: What it means for investors - US Post News
NovaBay sells Avenova brand to PRN for $9.5 million - Investing.com
PRN Nutriceuticals agreed to acquire Assets of Avenova Brand and Business of NovaBay Pharmaceuticals, Inc.. - Marketscreener.com
NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders - Business Wire
NovaBay sells Avenova brand to PRN for $9.5 million By Investing.com - Investing.com South Africa
NovaBay Pharma Announces Avenova Sale and Planned Dissolution - TipRanks
Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals - PR Newswire
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets - StockTitan
Impetigo Drugs Global Strategic Business Report 2024 - GlobeNewswire Inc.
Was there any good news for Novabay Pharmaceuticals Inc (NBY) stock in the last session? - US Post News
Novabay Pharmaceuticals Inc Inc. (NBY) Price Performance: The Role of Supply and Demand - The InvestChronicle
NovaBay Pharmaceuticals (NYSE:NBY) Announces Quarterly Earnings Results - Defense World
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2024 Earnings Call Transcript - Insider Monkey
Novabay Pharmaceuticals Inc (NBY)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
NovaBay Pharmaceuticals Reports Mixed Second Quarter 2024 Financial Results - Vision Monday
Earnings call: NovaBay Pharmaceuticals reports growth in eyecare By Investing.com - Investing.com Canada
Earnings call: NovaBay Pharmaceuticals reports growth in eyecare - Investing.com
Novabay Pharmaceuticals Inc (NBY) 財務データ
収益
当期純利益
現金流量
EPS
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):